CEA

Journey Medical Corporation Announces Successful Completion of Pre-NDA Meeting with the FDA for DFD-29 to Treat Rosacea

Retrieved on: 
Wednesday, December 6, 2023
Marketing, Entrepreneurship, Food, CEA, Minocycline, Rosacea, FDA, Capsule, NDA, Red, Patient, Skin, Food and Drug Administration, Erythema, Pharmaceutical industry

DFD-29 is being developed in collaboration with Dr. Reddy’s Laboratories Ltd.

Key Points: 
  • DFD-29 is being developed in collaboration with Dr. Reddy’s Laboratories Ltd.
  • The purpose of the meeting was to discuss the 505(b)(2) NDA submission plan for DFD-29 for the treatment of inflammatory lesions (papules and pustules) and erythema of rosacea.
  • During the pre-NDA meeting and in the official meeting minutes, the FDA agreed that the proposed data package is sufficient to support the NDA submission, which the Company continues to anticipate will occur around year-end of 2023.
  • The Phase 3 clinical trials achieved all co-primary and secondary endpoints and subjects completed the 16-week treatment with no significant safety issues.

Edible Garden to Showcase USDA Organic Produce and Sustainable Initiatives at 2023 New York Produce Show and Conference on December 6th

Retrieved on: 
Tuesday, December 5, 2023
Edible, Conference, CEA, USDA, Tea

The New York Produce Show and Conference, a world-class event for the industry, is presented by the Eastern Produce Council and PRODUCE BUSINESS Magazine.

Key Points: 
  • The New York Produce Show and Conference, a world-class event for the industry, is presented by the Eastern Produce Council and PRODUCE BUSINESS Magazine.
  • The highlight of the event is a one-day trade show on December 6th consisting of more than 400 companies, providing producers and retailers the opportunity to network, build relationships, and conduct business.
  • Additionally, we will be exhibiting our Pulp product line of sustainable, gourmet, USDA organic, fermented sauces and chili-based products which highlight our continued commitment to environmental stewardship and product innovation.
  • This show is a great platform for engaging with our retail partners, buyers, suppliers, and industry leaders.”

Edible Garden Posts Over 45% Year-Over-Year Increase in Preliminary Sales Results During Key Thanksgiving Time Period

Retrieved on: 
Tuesday, November 28, 2023
Walmart, Edible, Meijer, CEA, H Mart

BELVIDERE, NJ, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally grown, organic, and sustainable produce and products, today announced that the Company experienced an over 45% year-over-year increase in preliminary sales results for the Thanksgiving holiday.1

Key Points: 
  • Understanding the drivers of our success is key, notably our 98.5% fulfillment rate, which ranks among the industry's best.
  • These partners have come to recognize and value Edible Garden for our high-quality, locally sourced, organic, and sustainably produced goods, all of which are integral to our Zero-Waste Inspired® mission.
  • We believe that our reputation for dependability and quality is not only appreciated by our existing partners but also positions us attractively for future expansion of our distribution network.
  • Our vision is to continue to build upon this momentum, ensuring that Edible Garden remains synonymous with quality, sustainability, and reliability in the years to come.”

Edible Garden Deploys Grant Funded Technology from BRISEA; Recently Funded New Grant Received from NJ Economic Development Authority

Retrieved on: 
Friday, November 17, 2023
Edible, NJIT, EPA, St. Raphael's Edible Garden, Safety, USDA, Municipal solid waste, Partnership, Atmosphere, Water, CEA

BELVIDERE, NJ, Nov. 17, 2023 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally grown, organic, and sustainable produce and products, today announced a partnership with high-tech firm BRISEA Group Inc, to deploy BRISEA’s nanobubble generator demo unit at the Company’s Belvidere, New Jersey facility.

Key Points: 
  • BELVIDERE, NJ, Nov. 17, 2023 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally grown, organic, and sustainable produce and products, today announced a partnership with high-tech firm BRISEA Group Inc, to deploy BRISEA’s nanobubble generator demo unit at the Company’s Belvidere, New Jersey facility.
  • Mr. Jim Kras, Chief Executive Officer of Edible Garden, commented, "We are pleased to partner with BRISEA Group Inc., a leading provider of end-to-end prototyping services for environmental applications including water, air, and solid waste treatment, which was granted approval by the NJ Economic Development Authority (NJEDA) for the Demo Project Grant as part of the recently funded NJEDA CSIT Pilot Clean Tech Demonstration Grant Program, for a two-year nanobubble generator demonstration and evaluation, a major milestone in the study of nanobubble technology.
  • The deployment of the agricultural nanobubble generator unit at our Belvidere, New Jersey facility aims to demonstrate both the capabilities and the potential impact of the innovative technology.
  • We believe this collaboration holds immense promise for revolutionizing green agriculture practices, and we are eager to showcase the potential benefits.”

Edible Garden Reports 19.4% Year-Over-Year Revenue Growth for Third Quarter of 2023

Retrieved on: 
Monday, November 13, 2023
Cream, Ice cream, St. Raphael's Edible Garden, Dierbergs Markets, Acquisition, Meijer, Telephone, Financial result, Security (finance), Plant, Tops Friendly Markets, Depreciation, Health, Vitamin, Display, CEA, Growth, Ice Cream Cake (EP), Potato, Patent, Dr. Greenthumb, Walmart, Clothing, Retail, Video game, Cryptocurrency, Edible, Pulp

Mr. Jim Kras, Chief Executive Officer of Edible Garden, stated, "We are pleased to report year-over-year revenue growth of 19.4% for the third quarter of 2023.

Key Points: 
  • Mr. Jim Kras, Chief Executive Officer of Edible Garden, stated, "We are pleased to report year-over-year revenue growth of 19.4% for the third quarter of 2023.
  • Additionally, Edible Garden is enhancing its infrastructure and refining its data analytics capabilities, as we pursue opportunities to boost profit margins.
  • As an example, we partnered with Woodman’s Markets, which introduced Edible Garden produce and products to their 19 stores throughout Wisconsin and Illinois.
  • During the third quarter, Edible Garden introduced EG Direct, which is dedicated to sourcing and supplying partner-grown produce to its retail distribution network partners.

Median Technologies and PASREL-Imagerie Join Forces to Deliver Smart Imaging Biomarkers Supporting the Development of New Oncology Drugs in Precision Medicine

Retrieved on: 
Thursday, December 14, 2023
Biotechnology, Technology, Health, Radiology, Oncology, Medical Devices, Research, Software, Artificial Intelligence, Science, Clinical Trials, Acquisition, Medicine, Bent Image Lab, Molecular imaging, CEA, Biomarker, Knowledge, Drug development, Medical imaging

Median Technologies (Paris:ALMDT) and PASREL-Imagerie, announce today the signing of an agreement to deliver cutting-edge imaging biomarkers for the development of new oncology drugs in the era of precision medicine.

Key Points: 
  • Median Technologies (Paris:ALMDT) and PASREL-Imagerie, announce today the signing of an agreement to deliver cutting-edge imaging biomarkers for the development of new oncology drugs in the era of precision medicine.
  • By leveraging its expertise in medical imaging, PASREL-Imagerie will bring its know-how and support to Median in the implementation of advanced imaging biomarkers for early phase oncology trials.
  • The resulting knowledge would enable the biopharmaceutical industry to develop new drugs more effectively, while making the drug development cycle safer and shorter.
  • “By creating Imaging Lab in 2022, we showed our commitment to providing advanced imaging technologies to the biopharmaceutical industry.

ComEd, EPRI Collaborate on Sustainable Electric Technology to Help Grow Healthy Food Year-Round

Retrieved on: 
Wednesday, December 13, 2023
Oil, Gas, Agriculture, Natural Resources, Alternative Energy, Energy, Emerald, EPRI, Edible, Lighting, Research, NIU, Safety, Organization, D, University of Illinois Urbana-Champaign, Bed, Vegetable, YMEN, LED, Farmer, AG, Northern Illinois University, CEA, Water, HVAC, Temperature, Education, Renewable energy, Commonwealth Edison

The container uses electric technologies to create a microclimate that optimizes plant production and helps meet other community energy, water, and sustainability goals.

Key Points: 
  • The container uses electric technologies to create a microclimate that optimizes plant production and helps meet other community energy, water, and sustainability goals.
  • “ComEd is proud to collaborate on this exciting project that will help sustainably increase access to healthy food in our communities and provide agricultural learning opportunities using this innovative farming method,” said Gil C. Quiniones , CEO of ComEd.
  • “This project has brought together more than 20 neighborhood organizations all committed to the same vision of healthy lives and healthy families.
  • Other trackable data will help address questions regarding distribution planning, rate design, and larger societal benefits.

Employers Brace for New Laws in 2024 with Guidance From California Employers Association

Retrieved on: 
Wednesday, December 13, 2023
Public Policy, Government, Other Professional Services, Legal, Human Resources, State, Local, Small Business, Labor, Professional Services, AI, Sick leave, CEA, HR, Nursing, Audit

California is known for pioneering new employment laws and 2024 is no exception with businesses facing many new laws and expansion of existing laws.

Key Points: 
  • California is known for pioneering new employment laws and 2024 is no exception with businesses facing many new laws and expansion of existing laws.
  • New laws also require employers to update required labor law posters and employee handbook policies.
  • “To help employers understand what these new laws mean for their company, CEA has compiled a free guide detailing highlights of the new requirements and practical action steps,” added Gusman.
  • https://www.employers.org/events/virtual-events/2024-labor-law-update-sp...
    Founded in 1937, CEA is a non-profit association providing customized support to employers of all sizes with their California compliance needs, including Out-of-State employers with California employees.

Osivax Receives Over USD 1.5M Grant from NIAID to Advance Development of Broad-Spectrum Influenza Vaccine Candidate, OVX836

Retrieved on: 
Tuesday, December 5, 2023
Research, Other Health, Pharmaceutical, White House, Federal Government, Infectious Diseases, Other Manufacturing, Clinical Trials, Science, Biotechnology, Health, Public Policy, Government, Other Science, Manufacturing, NIAID, Safety, Sustainable energy, Entrepreneurship, Principal investigator, Risk, Innovation, Vaccine, USD, Infection, NIH, Human, CEA, Influenza, Public

The grant (project number 1R01AI177376) will support preclinical studies evaluating the breadth of protection and immune response induced by the company’s lead, broad-spectrum influenza vaccine candidate, OVX836 against pandemic influenza strains.

Key Points: 
  • The grant (project number 1R01AI177376) will support preclinical studies evaluating the breadth of protection and immune response induced by the company’s lead, broad-spectrum influenza vaccine candidate, OVX836 against pandemic influenza strains.
  • The IDMIT is highly specialized in human infectious diseases and has the facilities needed for testing the immunogenicity and efficacy of OVX836 as a vaccine against pandemic influenza strains in preclinical models.
  • “Receiving this grant from the NIAID will support our progress in developing OVX836 to provide broad-spectrum protection against influenza, which remains a perennial pandemic threat,” commented Alexandre Le Vert, Co-Founder and CEO of Osivax.
  • Osivax also recently published the results of a Phase 2a dose-optimization study ( OVX836-003 ) in The Lancet Infectious Diseases showing efficacy in humans against seasonal strains.

Global Indoor Farming Systems Market Report 2023: Innovation Ecosystem, Patent Landscape, Technology Analysis, Strategic Imperatives, Growth Opportunity Analysis - ResearchAndMarkets.com

Retrieved on: 
Monday, December 4, 2023
Technology, Agritech, Agriculture, Natural Resources, Pandemic, Lighting, Climate change, Food, Transport, Plant, UN, Urbanization, Food and Agriculture Organization, Weather, Humidity, Farmer, Patent, Food security, CEA, Water, United Nations, FAO, Strategy, Population growth, System, Drought, Temperature, Par value, Poultry farming, Growth

The "Technology Advances in Indoor Farming Systems" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Technology Advances in Indoor Farming Systems" report has been added to ResearchAndMarkets.com's offering.
  • This study on the technological advances in indoor farming systems provides a comprehensive analysis of indoor farming technologies, trends, and factors driving the development and adoption of various farming systems.
  • It explores the patent landscape and growth opportunities enabling the development and adoption of indoor farming, It also goes into details of major stakeholders active in the indoor farming landscape.
  • Indoor farming incorporates advanced farming techniques classified as controlled environment agriculture (CEA) that comprises technologies to optimize growing conditions for plants.